AmideBio is a biotechnology company that is leveraging its proprietary BioPure™ platform technology to deliver difficult-to-manufacture peptides and build a pipeline of novel biotherapeutics.

The Company exclusively licensed the platform technology in 2010 from University of Colorado and is aggressively pursuing patent protection for all key improvements, as well as our proprietary peptide therapeutics.